Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Assessing The Future Of Robotics In Medtech

Executive Summary

Andy Kach, a principal in ZS's Medical Products and Services practice, offers his perspective on the “war of the robots” in the surgical technology market. He argues that companies that focus on specialized, expensive technologies will eventually cede market share to systems that are multifunctional, portable, and valuable to multiple surgical departments.

You may also be interested in...



Rising Procedure Volumes Push Intuitive Surgical Third-Quarter Earnings Above Forecast

Intuitive Surgical reported higher-than-expected third-quarter revenues with strong procedure growth and ongoing adoption of the da Vinci system in the US and outside of the US.

Mako Robot Sales Drive Stryker’s Orthopedics Business In Second Quarter

Stryker reported organic growth of 8.5% during the second quarter of 2019 led by 12% growth in the medical and surgical equipment business, 7% growth in neurotechnology and spine revenue, and 6% growth in sales of orthopedic devices, led by the Mako robotic surgery system.

Zimmer Biomet Continues Turnaround Lead by ROSA Robot

Zimmer Biomet’s net sales were up 1.2% year-over-year in the second quarter. CEO Bryan Hanson said the ROSA Knee robotic surgery system is performing even better than expected since it launched earlier this year, and is expected to be an important revenue-driver in the future.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT125464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel